The investigators believe that glucagon therapy will have a positive impact on key parameters
of colonoscopy such as cecal intubation time, withdrawal time, total procedure time, adenoma
detection rate, endoscopist's assessment of the difficulty of the procedure, patient comfort,
and patient's willingness to undergo a repeat colonoscopy.